Nearly 300,000 bottles of the drug, named Cinacalcet, were recalled and given a Class II recall risk level by the FDA.
The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new ...
Costco customers with dairy allergies may need to check their fridge because 80,000 pounds of the retailer's butter was ...
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...
The agency has placed a partial hold on the phase 2a PORTOLA trial evaluating the selective immunoproteasome inhibitor ...
PK Study Successfully Demonstrates that Fingerprint Sweat Provides Reliable Sample for Drug Detection. FDA 510(k) Clearance ...
In the wake of an unfavorable advisory committee meeting in September, Intercept Pharmaceuticals’ bid to win full approval ...
Robert F. Kennedy Jr., one of President-elect Donald Trump’s advisers on health, is taking aim at the agency’s oversight on ...
The products are part of the agency's ongoing public health alert concerning cinnamon with elevated lead levels ...
Salim Syed’s rating is based on the positive regulatory feedback from the FDA regarding Wave Life Sciences’ lead candidate, WVE-003, for Huntington’s disease. The FDA’s openness to a pathway for ...